Skip to main content

Advertisement

Table 3 Summary of AEs

From: Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

  Grade 1 Grade 2 Grade 3 Grade 4
Patients with a treatment-related AE, n (%) 21 (28.4) 16 (21.6) 7 (9.5) 1 (1.4)
All events by maximum reported grade, n
Any 68 23 7 1
Pruritus 10 3   
Diarrhoea 6 4 2  
Pain 7 2 2  
Fever 8 1 1  
Anaemia 6 1   
Rash 5 2   
Nausea 6    
Asthenia 5    
Cough 2    
Dyspnoea 1 1   
Hyperthyroidism 2    
Hypothyroidism   2   
Infection   2   
Scrotal pain 1 1   
Dermatitis   1   
Oedema   1   
Epigastric pain    1  
Herpes Zoster   1   
Hypocalcemia   1   
Increase in aspartate transaminase/alanine transaminase    1  
Pancytopenia     1
Other* 9    
  1. * Single AEs of grade 1 intensity: penis bleeding, cephalea, confusion, fatigue, constipation, anorexia, inappetence and dysgeusia, flu-like syndrome, ocular Herpes Zoster with oedema and pain.
  2. AEs adverse events.